Idexx Laboratories (IDXX) Net Shares Issued and Repurchased (2011 - 2017)
Idexx Laboratories (IDXX) posted Net Shares Issued and Repurchased of $384000.0 for Q4 2017, down 48.46% on a QoQ basis from $745000.0 in Q4 2016, and down 48.46% year-over-year from $745000.0 in Q4 2016.
Analysis
Idexx Laboratories (IDXX) Net Shares Issued and Repurchased (2011 - 2017) Analysis & Trends
Idexx Laboratories has reported Net Shares Issued and Repurchased for 7 years, with the latest figure at $384000.0 in Q4 2017.
- On a quarterly basis, Net Shares Issued and Repurchased fell 48.46% year-over-year to $384000.0 in Q4 2017; TTM through Dec 2017 was $384000.0, a 48.46% decrease from a year earlier, with the FY2017 full-year figure at $384000.0, down 48.46% from the prior year.
- Net Shares Issued and Repurchased was $384000.0 for Q4 2017 at Idexx Laboratories, down from $745000.0 in the prior quarter.
- The five-year high for Net Shares Issued and Repurchased was $745000.0 in Q4 2016, with the low at $297000.0 in Q4 2014.
- Average Net Shares Issued and Repurchased over 5 years is $484600.0, with a median of $386000.0 recorded in 2013.
- The sharpest annual moves came in 2015 and 2017: Net Shares Issued and Repurchased surged 105.72% in 2015, then tumbled 48.46% in 2017.
- Over 5 years, Net Shares Issued and Repurchased stood at $386000.0 in 2013, then fell by 23.06% to $297000.0 in 2014, then soared by 105.72% to $611000.0 in 2015, then rose by 21.93% to $745000.0 in 2016, then sank by 48.46% to $384000.0 in 2017.
- The last three Net Shares Issued and Repurchased figures came in at $384000.0 (Q4 2017), $745000.0 (Q4 2016), and $611000.0 (Q4 2015), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | - |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | - |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | - |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 3,161.00 |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 384,000.00 |
| Dec 31, 2016 | 745,000.00 |
| Dec 31, 2015 | 611,000.00 |
| Dec 31, 2014 | 297,000.00 |
| Dec 31, 2013 | 386,000.00 |
| Dec 31, 2012 | 302,000.00 |
| Dec 31, 2011 | 546,000.00 |